Cargando…
Multiple chemical scaffolds inhibit a promising Leishmania drug target
The need for an effective oral therapy for leishmaniasis is addressed through the study of the target N-myristoyltransferase from Leishmania major.
Autor principal: | Walkinshaw, Malcolm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107919/ https://www.ncbi.nlm.nih.gov/pubmed/25075340 http://dx.doi.org/10.1107/S2052252514014572 |
Ejemplares similares
-
Neurofeedback for tinnitus treatment: an innovative method with promising potential
por: Kleinjung, Tobias, et al.
Publicado: (2023) -
Vessel wall imaging: a promising enhancement in the management of inflammatory intracranial vasculopathy
por: Yang, Dixon, et al.
Publicado: (2022) -
Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test
por: Teunissen, Charlotte E, et al.
Publicado: (2020) -
Eigenvector centrality and its variability over time are promising indicators of alterations in brain function due to early amyloid deposition
por: Skouras, Stavros
Publicado: (2023) -
Synthesis of chemically stable covalent organic frameworks in water
por: Chong, Samantha Yu-ling
Publicado: (2016)